Anaplasmosis Treatment Market Worldwide Key Players Forecasts By Revenue, Growth Rate Till 2023

Market Highlights

Anaplasmosis is a zoonotic disease affecting dogs, cats, livestock, wildlife, and human. It is highly unlikely that a person will contract anaplasmosis from pets directly, but pets could bring ticks with the infection into home, posing a risk to the family. If a pet is diagnosed with anaplasmosis, precautionary measures to reduce the risk of infection. The disease is known as human granulocytic anaplasmosis (HGA) in people, canine granulocytic anaplasmosis in dogs, equine granulocytic anaplasmosis in horses, and tick-borne fever in ruminants.

Favorable government policies for research and the presence of a large number of players in the global anaplasmosis treatment market are the key factors driving the growth of the market during the forecast period.

Regional Analysis

Global anaplasmosis treatment consists of regions namely the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The America is dominating the global anaplasmosis treatment market owing to the high prevalence rate of this disease in the eastern regions. European holds the second largest share of the global anaplasmosis treatment market owing to the increasing research and development in biotechnology and pharmaceutical companies ,especially for study of diagnostic testing.

Asia Pacific is expected to be the fastest growing region and is anticipated to compete with the American market during the forecasted period 2017-2023. Anaplasmosis remains an uncontrolled problem in regions of high endemicity such as the Mediterranean, the Middle East, Africa, Latin America and parts of Asia. The presence of anaplasmosis in India was first established early in the previous century and since then has been reported from almost all states. Furthermore, tick diseases are the most common bacterial laboratory acquired infection worldwide.

Segmentation

The anaplasmosis treatment market is segmented on the basis of species, diagnosis, application, treatment, and end-users.

On the basis of the species, the market is segmented into Deer tick (Ixodes scapularis), western black-legged tick (Ixodes pacificus), Anaplasmosis phagocytophilum or A. platys

On the basis of the diagnosis, the market is segmented into enzyme-linked immunosorbent assay (ELISA), indirect fluorescent antibody (IFA), and polymerase chain reaction (PCR) tests

On the basis of the application, the market is segmented into humans, pets, livestock, wildlife, and others 

On the basis of the treatment, the market is segmented into antibiotics, vaccines, and others. The antibiotics can be further classified as doxycycline, tetracyclines, chlortetracycline, oxytetracycline, rolitetracycline, minocycline and others.

On the basis of the end-user, the market is segmented into hospitals & diagnostic centers, academic institutes, pharmaceutical & biotechnology companies and others.

Key Players

Some of key the players in the global anaplasmosis treatment market are Wyeth Pharmaceuticals (U.S.), Merck Sharp & Dohme (France), Boehringer Ingelheim (France), Bristol-Myers Squibb and Company (U.S.), Glaxosmithkline Inc. (U.S.) Aventis Pharma (Canada), Mylan Pharmaceuticals (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals (Israel), Shire (U.S.), Procter & Gamble, (U.S.), Duramed Pharmaceuticals (U.S.), Takeda Pharmaceuticals (Japan), Ciba Vision (Germany) and Novopharm (Canada).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/anaplasmosis-treatment-market-5351

Bone Biopsy Market Rise With Magnifying Growth Rate | Forecast By 2025

Market Scenario

Bone Biopsy market growth is driven by increasing prevalence of chronic diseases such as Chronic Kidney Disease (CKD) and demand new diagnostic services. Additionally, increasing research and development activities, technological advancements to identify the causes and risk factors associated with osteopenia and osteoporosis also fuel the market growth of global market.

The Global Bone Biopsy System Market is expected to grow at a CAGR of 5.7% during the forecast period.

According to the World Health Organisation (WHO), cancer was the leading cause of the total number of deaths globally as of 2015 and was responsible for 8.8 million deaths. The most common causal agents identified are cigarettes, cigars, pipes and chewing tobacco. According to the Cancer Research U.K, looking at the lifestyle factors responsible, it has been found that out of 3 diagnosed cases, 1 may be linked to smoking.

Bone biopsy is performed to diagnose various bone disorders such as bone cancer, bone infection, osteoporosis and chronic kidney disease. Nowadays, biopsy procedure has received great importance in oncology as one of the promising methods in cancer diagnostics. The demand for needle biopsy is found to be increasing from last few years.

Key Players in the Global Bone Biopsy Market     

• C R Bard (U.S.),
• Becton,
• Dickinson and Company (U.S.),
• Braun Melsungen AG,
• Hologic, Inc. (U.S.),
• Cook Medical (U.S.),
• Devicor Medical Products Inc. (U.S.),
• Argon Medical Inc. (U.S.)

Segmentation      

The global bone biopsy market is segmented on the basis of type, indication and end user.

On the basis of the component, market is segmented into needle biopsy and open biopsy.

On the basis of the application, the market is segmented into bone cancer, bone infection, chronic kidney disease, osteoporosis, and others

On the basis of the end user, the market is segmented into hospital & clinics, surgical centers, diagnostic centers, and others.

Regional Analysis

America holds the first position in the bone biopsy market owing to the rising prevalence of cancer in the U.S. and increasing demand for new cancer diagnostic and treatment services. In Americas, North America is the largest market owing to the presence of key players in healthcare diagnostic industry. The prevalence of osteoporosis is found to be higher in the population over 35 years for age. Changing lifestyle, emphasis on fitness and exercise, and overall development of medical device industry also accelerate the growth of the market.

Europe is the second largest market for bone biopsy. In Europe, there is an increasing demand for advanced bone biopsy devices, and extensive research and development activities by clinical research and academic institutes for cancer diagnosis and treatment. Germany is the largest market followed by France. The market in Germany is driven by increasing demand for specialty care services.

The market in Asia Pacific is expected to grow at the fastest pace and is driven by the high prevalence of chronic disease such as kidney disease, obesity, diabetes and other. India, China, and Japan are major contributors to the growth of the market. This growth is attributed to an increasing demand of technologically advanced medical devices in diagnostic centers and availability of highly qualified medical professional dedicated to research in oncology. Additionally, rising healthcare expenditure and extensive growth of medical device industry also influence the use of medical devices for diagnosis of various diseases such as osteoporosis, diabetes, cancer, and others.

The Middle East & Africa also show a steady rise in the market owing to low technology penetration and increasing awareness about cancer treatment. In the Middle East & Africa, United Arab Emirates captures the largest market share for bone biopsy owing to the availability of better healthcare infrastructure and a wide scope for research. In Africa, the market also shows a positive growth owing to development of healthcare system in African countries, and increasing demand for primary care services.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/bone-biopsy-market-5341

Telehealth Market To Gain An Upward Trend In Upcoming Years, Analysis On Impact Of Covid-19

Market Research Future (MRFR) collected data on several factors including implications of covid-19 impact on microbiome sequencing services market and demographic challenges, showed how it could move forward in the coming years.

Global Telehealth Market size is expected to register a CAGR of 22.74% to reach USD 16,173.8 Million by 2024. Telehealth is the use of digital information and communication technologies to access healthcare services remotely for the management of health. Telehealth connects patients to fundamental healthcare services through remote monitoring, video conferencing, electronic consultations, and wireless communications. Factors such as the increasing prevalence of chronic diseases, the rise in geriatric population, and the shortage of physicians are the major drivers propelling the telehealth market growth. However, privacy and security concerns and stringent government rules for telehealth services could hamper market growth during the forecast period.

Impact 0f COVID-19 on the Telehealth Market

1.1 A HISTORICAL PERSPECTIVE

It did not take novel coronavirus for the telehealth industry to start gaining traction among healthcare providers and patients. Telehealth was already experiencing significant momentum and growth prior to this public health emergency, particularly over the past few years as the technology has become more streamlined and young tech-savvy generation is gaining interest in this care model. The appetite for telehealth is growing, but many consumers are confused or unsure about its availability.

We have observed the massive impact of novel coronavirus on people’s lives over the last five months. It has also impacted various industries across the globe, eventually affecting the global economy. Some industries have experienced negative growth, whereas some industries have experienced tremendous demand and have generated massive revenues in this period. Covid 19 Impact on Telehealth market is the one of the positive impact sector on global industry

Telehealth Market Dynamics

Telehealth could be effectively utilized for the diagnosis, treatment, and supportive care of chronic diseases such as diabetes and cancer. Chronic diseases reduce a person’s quality of life, especially if left undiagnosed or untreated. According to data by the Government of Canada, in 2017, about 2.3 million people aged 12 and older were diagnosed with diabetes. Additionally, according to the press release by Chiron Health published in June 2016, chronic diseases such as heart disease, stroke, cancer, depression, type 2 diabetes, obesity, and arthritis affected an estimated 117 million people in the Americas. Telehealth can be used to address the rising demand for healthcare services for cancer, diabetes, and other diseases in developing regions. Thus, the high prevalence of such diseases is estimated to drive market growth during the forecast period.

Telehealth Market Key Players

The prominent players in the global telehealth market are Boston Scientific Corporation (US), AMD Global Telemedicine Inc. (US), Siemens (Germany), Allscripts Healthcare Solutions (US), Right Health (Canada), American Well (US), GlobalMed (US), Care Innovations LLC (US), Honeywell International Inc. (US), InTouch Technologies Inc. (US), Medtronic PLC (Ireland), Philips Healthcare (Netherlands), Cerner Corporation (US), Dialogue (Canada), Maple (Canada), Cisco Systems Inc. (US), and Livecare Health (Canada).

Telehealth Market Segmentation

Global telehealth market report has been segmented into component, mode of delivery, application, and end user.

Global telehealth market analysis, by component, has been segregated into services, software, and hardware. The services segment accounted for the largest share owing to the increasing initiatives by key companies, whereas the software segment is expected to be the fastest-growing due to the growing inclination toward the usage of telehealth software. The market, by hardware, has been further sub-segmented into monitoring devices, medical peripherals, and others. The market, by monitoring devices, has been sub-segmented into stationary and wearable monitoring devices. The market, by medical peripherals, has been further divided into blood pressure monitors, ECG monitors, pulse oximeters, blood glucose meters, peak flow meters, otoscopes, and others. The market, by software, has been segregated into integrated software and standalone software. The market, by services, has been further classified as remote monitoring, real-time interactions, and store-and-forward consultations.

The global telehealth market, by mode of delivery, has been divided into web/cloud-based and on-premise. The web/cloud-based segment held a large share due to the wide preferability, whereas the on-premise segment is projected to be the fastest-growing due to the increasing awareness among hospital management.

The global telehealth market, by application, has been categorized as radiology, cardiology, primary care, neurophysiology, and others. The radiology segment held a major share owing to the increased use of telehealth technology in the radiology field, whereas the cardiology segment is projected to be the fastest growing owing to the rise in cardiovascular diseases.

The global telehealth market, by end user has been classified as hospitals and clinics, diagnostic clinics, home care, and others. Hospitals and clinics segment held a major share due to the increase in the number of hospitals employing the use of telehealth software, whereas the diagnostic clinics segment is expected to be the fastest-growing segment due to the rising inclination towards telehealth services.

Telehealth Market Regional Analysis

Global telehealth market share, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is estimated to dominate the global telehealth market. This can be attributed to the increasing adoption of telehealth services in the US. For instance, in 2016, Kaiser Permanente, an integrated managed care consortium based in California, conducted more consultations virtually than in person, i.e., nearly 52% of 110 million physician visits were via online portals, virtual visits, or apps.

The Europe market for telehealth is expected to be the second largest market. The paradigm shift toward more organized and continuous healthcare monitoring is projected to be the main factor for the growth of the market extensively. Italy held a share of 12.4% in the Western Europe telehealth market in 2018.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/report/covid-19-impact-telehealth-market

Asia-Pacific is estimated to be the fastest-growing region in the global market due to the rise in geriatric population, an increase in the prevalence of chronic diseases, and the shortage of technical personnel.

The Middle East & Africa is expected to witness steady growth due to limited access and healthcare affordability among the population.

Covid-19 Impact And Recovery Analysis: Clear Aligners Market Is Expected To Witness Significant Growth During The Forecast Period

Market Research Future (MRFR) collected data on several factors including implications of covid-19 impact on microbiome sequencing services market and demographic challenges, showed how it could move forward in the coming years.

Global Clear Aligners Market size is expected to register 20.80% CAGR and is anticipated to reach USD 7019.96 Million by 2025. 

Clear aligners are an alternative to traditional braces and are designed to help arrange teeth into their proper position. Similar to braces, clear aligners use a gradual force to control the tooth movement, but without metal wires or brackets. The aligners are made of a durable plastic material and are fabricated to fit each individual's mouth.

Global clear aligners market share is driven by the increase in youth and geriatric population, growing dental service organizations, increase in dental procedures, and the rising prevalence of dental diseases. However, factors such as complications of clear aligners and the gray market for dental distribution are expected to restrict market growth during the forecast period.

Impact of Covid-19 Global Clear Aligners Market

The COVID-19 epidemic has been straining healthcare workflow across the globe. The disease has forced various industries to temporary shut its doors including many healthcare subdomains. Clear aligners have been one of the major markets that has been negatively impacted by COVID-19. The production for clear aligners has been disrupted across the globe. COVID-19 has forced various dentists to slash their services and staff resulting in delay in large number of appointments which is leading to increasing complications. Also, various events with respect to dental and clear aligners have been suspended. These events were supposed to be conducted in accordance to increase awareness and improve revenue for clear aligners. The company exocad, recently acquired by Align Technology, announced that its Insights 2020 event would be delayed to September 2020. Furthermore, the third congress of the European Aligner Society, which was supposed to be held in Malta from 19 to 21 March 2020, has been shifted to November 2020. The aim of this event was to introduce advances in technologies and techniques in aligner orthodontics and also major opportunity for various large manufacturers to enter into strategic alliances.

The company Align Technology, one of the leading players, accounts for more than 70% of the market share across the globe is also facing challenges in generating revenue due to COVID-19. In March, the company’s stock fell down by 20%. The analysis shows that the major reason for this was the lockdown in China where the company generated 8% of its entire revenue. The outcome of this lockdown is expected a $30 million to $35 million hit on revenue for the first quarter alone.

We have observed the massive impact of novel coronavirus on people’s lives over the last five months. It has also impacted various industries across the globe, eventually affecting the global economy. Some industries have experienced negative growth, whereas some industries have experienced tremendous demand and have generated massive revenues in this period. Covid 19 Impact on Clear Aligners market is the one of the positive impact sector on global industry

Clear Aligners Market Dynamics

The increasing expenditure on healthcare has minimized human efforts and increased the quality of patient care services. Moreover, the development of advanced technology in the healthcare industry has improved and provided many facilities to patients as per their needs, driving the growth of the global clear aligners market. For instance, according to the Official Portal of the UAE Government, approximately AED 3.83 billion (USD 1.00 billion) was allocated to the healthcare sector in 2015 in the UAE. Following the same course, AED 4.2 billion (USD 1.099 billion) was allocated for the healthcare and protection society in 2017.

Moreover, the growing youth and geriatric population, increasing prevalence of dental diseases, and technological advancements in dentistry are also expected to provide favorable conditions to the growth of the market during the forecast period.

However, the limitations of clear aligners and grey market for dental distribution are creating hurdles in the growth of the global clear aligners market.

Segmentation

The global clear aligners market has been segmented into product type, age, distribution channel, and region. 

Based on product type, the global market has been segmented into hard, medium, and soft.

Based on age, the global market has been divided into teenager and adult. The teenager segment is likely to hold the maximum share in the global market with a value of 1427.98 million in 2018.

Based on distribution channel, the global market has been divided into direct sales and distributor.

Clear Aligners Market Key Players

The prominent players in the global clear aligners market are Align Technology, Inc., Dentsply Sirona, Institut Straumann AG, Clarus Company, Danaher Corporation, and 3M.

Some of the key strategies followed by the players operating in the global clear aligners market were innovation, product development, acquisition, and expansion.

Regional Analysis

Global clear aligners market, based on region, is segmented into– the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The Americas is expected to command the largest market share due to aesthetic dentistry and other vast specialized services present in countries of North America. Additionally, the rising health expenditure per person and increasing demand for advanced technologies are driving the growth of the clear aligners market in these countries. Additionally, the presence of a large number of noticeable players in this region is the major driving factor of the market in the Americas.

Europe accounts for the second-largest market, majorly due to the soaring demand for dental procedures. Additionally, the increasing incidences of oral problems, vast application of technologically advanced techniques, and the growing importance of treatment, planning, and diagnosis in implant dentistry in European countries are driving the clear aligners market in Europe.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/report/covid-19-impact-clear-aligners-market

Asia-Pacific with lots of opportunities and continuously growing economies is expected to be the fastest-growing region. Furthermore, recent developments in healthcare and improving economies and disposable income per individual are fueling market growth.

The Middle East & Africa is expected to grow significantly during the forecast period due to the increasing cases of dental abnormalities and the demand for better teeth-related treatments in the region.

COVID-19 Impact On HEALTHCARE PERSONAL PROTECTION EQUIPMENT Market 2020: Growth Trends, Cost Structure, Driving Factors And Future Prospects 2027

Market Research Future (MRFR) collected data on several factors including implications of covid-19 impact on microbiome sequencing services market and demographic challenges, showed how it could move forward in the coming years.

Global Healthcare Personal Protection Equipment Market is expected to cross USD 10.116 Billion by 2027 at a CAGR of 9.17%.  

Market Synopsis

Personal Protective Equipment (PPEs) are protective gear designed to safeguard the health of workers by minimizing the exposure to a biological agent. It is one of the necessary tools in preventing transmission of infectious diseases not only in treatment centers but also in various activities, e.g. cleaning, waste management and safe burials, and community care related to the outbreak. Components of PPE are goggles, face-shield, mask, gloves, coverall/gowns (with or without aprons), head cover, shoe cover, and others.

Impact of Covid-19 Outbreak on Healthcare Personal Protection Equipment Market

Healthcare Personal Protection Equipment (PPE) are protective gears that are designed to safeguard the workers by minimizing the exposure to a biological agent. PPE helps healthcare workers to fight against novel coronavirus (COVID-19). The World Health Organization (WHO) has recommended several governments worldwide to increase the production of masks, gloves, respirators, and coveralls/gowns. It also recommended that PPE manufacturers must increase their production by 40% and prioritizing their orders to countries with a high demand-supply gap.   

Several countries, including India, have considered importing PPE kits to meet its requirements from China, Singapore, and South Korea. Although a tender was rolled out last week by the government's nodal procurement agency HLL Lifecare, the government has chosen not to wait for the bids to be released, rather than source it from other countries. As of the 3rd week of April, the coronavirus (COVID-19) pandemic crossed two million cases globally. The increasing demand for hand protection, respiratory protection, and protective clothing in the healthcare industry to ensure people’s safety during the ongoing COVID-19 pandemic is expected to boost the demand for PPE.  Furthermore, the increasing government initiatives to facilitate the import of PPE is expected to drive the market growth. For instance, in March 2020, in response to the COVID-19 outbreak, the Food and Drug Administration (FDA) initiated numerous steps to improve the US stocks of PPE. A few of its measures include adjustments in import screening, flexibility to manufacturers, and creation of special mailbox service, among other provisions.

We have observed the massive impact of novel coronavirus on people’s lives over the last five months. It has also impacted various industries across the globe, eventually affecting the global economy. Some industries have experienced negative growth, whereas some industries have experienced tremendous demand and have generated massive revenues in this period. Covid 19 Impact on Healthcare Personal Protection Equipment market is the one of the positive impact sector on global industry

Healthcare Personal Protection Equipment Market Influencer

PPE helps healthcare workers to fight against novel coronavirus (COVID-19). The World Health Organization (WHO) has recommended the governments across the world to increase the production of masks, gloves, respirators, and coveralls/gowns. It also recommended that PPE manufacturers must increase their production by 40% and prioritizing their orders to the countries with a high demand-supply gap.

Market Drivers

• As of the 3rd week of April, coronavirus (COVID-19) pandemic crossed 2 million cases globally. The increasing demand for hand protection, respiratory protection, and protective clothing in the healthcare industry to ensure the people’s safety during the ongoing COVID-19 pandemic is expected to boost the demand for Personal Protective Equipment (PPE).

• Rapid technological advancements in the field of surgery such as High-Reliability Organizing (HRO), technical advancements, and standardizing procedures are expected to have a positive impact on the hospital sector, thereby impacting the demand for personal protective equipment positively.

• Increasing government initiatives to facilitate the import of personal protective equipment is expected to drive the market growth. For instance, in March 2020, in response to the COVID-19 outbreak, the Food and Drug Administration (FDA) initiated numerous steps to improve US stocks of personal protective equipment. The measures include adjustments in import screening, flexibility to manufacturers, and creation of special mailbox service, among other provisions.

• The emergence of local PPE manufacturers, increasing end user demand, and the rising production of cost-effective and integrated PPE is expected to boost the market growth. For instance, in India, the Union Textiles Ministry and the Health Ministry has said the government is augmenting the supplies of personal protective equipment (PPEs), including body coveralls, N-95 masks and 2-ply/3-ply surgical masks required for healthcare professionals dealing with COVID-19 cases. Furthermore, more than 130 Australian companies have responded to an urgent call to dramatically boost the manufacturing of face masks, gowns, and gloves to deal with the COVID-19 crisis.

Market Restraints

• The current global stockpile of PPE is inadequate to handle the existing and expected cases in different parts of the world, particularly for medical masks and respirators. The supply of gowns and goggles is also expected to be insufficient as the disease is spread. Surging global demand is not only driven by the increasing number of COVID-19 cases but also by misinformation, hoarding, and panic buying. The lockdown in a significant portion of the world is hampering the manufacturing of PPE.

• The high cost of raw materials (specialized clothing and other related products) is hindering the demand for PPEs in economically weak countries.

Healthcare Personal Protection Equipment Market Segmentation

By Product

• Protective Clothing: The protective clothing is further segmented into coveralls, gowns, and others. Coverall/gowns are designed to protect the torso of healthcare providers from exposure to the virus.

• Respiratory Protection: Respiratory protection is bifurcated into surgical masks, respirator masks, and others. The healthcare professionals are recommended to use surgical N95 respirators or medical respirators to protect them from the direct exposure to the COVID-19 virus.

• Head, Eye, and Face Protection: The largest segment. To prevent exposure of the eye and face from the virus, goggles or a face shield should be considered. High risk of COVID-19 and other infections through nose, eyes, and ears is among the primary reason driving the growth for this segment. The goggles must fit the contours of the user’s face and are compatible with the respirator. The use of face shields/ goggles is an integral part of standard and contact precautions for the people most at risk of COVID-19 infection.

• Protective Footwear: The use of protective footwear such as washable and disposable footwear is essential to avoid self-contamination.

• Hand protection: Hand protection is further sub-segmented into general-purpose, chemical handling, sterile gloves, and surgical. The rising awareness about hygiene and prevention from the transmission of pathogens in healthcare facilities is increasing the demand for medical gloves.

• Others

By End Use

• Hospitals & Clinics: The largest segment and expected to grow at the highest CAGR during the forecast period. The rising awareness regarding the hand protection during a viral outbreak is increasing the demand for PPEs in hospitals.

• Ambulatory Surgical Centers: The increasing number of patients visiting surgical centers is facilitating the demand for PPEs in ambulatory surgical centers.

• Academic and Research Institutes: PPEs are very effective in minimizing occupational injuries, accidents, and other hazards which otherwise result in substantial manpower and financial losses. The use of basic PPE is a must in research institutes as they protect from skin contact and contamination.

• Diagnostic Laboratories: The use of protective equipment is necessary for diagnostic laboratories to protect healthcare workers from specific hazards and hazardous materials.

• Others

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/report/covid-19-impact-healthcare-personal-protection-equipment-market

By Region

• Americas: The largest regional market. The increasing government initiatives and rising concerns in terms of health and safety of healthcare professionals is boosting the demand for the same. Moreover, the rising prevalence of COVID-19 infection is majorly contributing to the growth of this region.

• Europe: The healthcare market in Northern European economies, such as Germany, U.K., and Sweden, is expected to exhibit an increase in healthcare expenditure, thereby leading to the growth in production as well as the consumption of medical devices and products.

• Asia-Pacific: The fastest-growing regional market. Emerging market players in the region, technological advancements, rising focus of government towards healthcare facilities, and high target population in the region are among the key factors driving the market growth in the region.   

• Middle East & Africa: The high penetration of personal protective equipment in developed healthcare industries of UAE, South Africa is expected to drive the growth of the market in this region. 

COVID-19 Impact on CBD Market In-Depth Analysis With Current Trends And Future Estimations

Market Research Future (MRFR) collected data on several factors including implications of covid-19 impact on microbiome sequencing services market and demographic challenges, showed how it could move forward in the coming years.

The Global CBD Market was valued at USD 570 Million in 2018 and is expected to register a CAGR of 125.58% during the forecast period.

Cannabidiol (CBD) is a safe, non-addictive substance found in the cannabis plant. CBD is the second-most abundant cannabinoid found in cannabis after tetrahydrocannabinol (THC). CBD has significant therapeutic benefits such as anti-inflammatory, analgesic, anti-anxiety, and seizure-suppressant properties. According to a survey by the National Center for Biotechnology Information (NCBI) conducted between 2017 and 2018, about 62% of the population used CBD to treat a medical condition.

The growing research & development and financial support by various private and government organizations for cannabinoid research, rising occurrence of chronic diseases and related complications, and legalization of CBD in various regions are expected to have a positive impact on the global cannabidiol (CBD) market. However, adverse effects associated with cannabis and stringent government policies are anticipated to restrain the growth of the global CBD market.

Unique Formulation of CBD is Being Tested for its Efficacy in Treating Viral Infections, including COVID-19.

The CBD terpene formulation is exclusively dedicated to the treatment and prevention of viral infections. It is precisely designed for high-risk populations and the prevention of infections such as the COVID-19 novel strain of coronavirus. In previous research projects that were undertaken since the outbreak of the SARS virus in 2002, CBD terpenes are effective antiviral agents and specific terpenes that came into contact with the SARS virus were found to decrease its severity and influence (both in-vitro and in-vivo) by withholding a certain protein that replicates the RNA. This prevents it from penetrating healthy cells and using them as hosts for its replication.

The novel formulation is intended to be consumed by direct inhalation. For instance, the Chairman of CannaSoul, Professor Dedi Meiri of the Israel Institute of Technology, said: “Our lab has been permitted to operate as a corona lab, and in doing so, we are encouraging two studies based on existing cannabis studies.

First, we will try to detect the plant’s molecules that are capable of overpowering the immune response to the COVID-19 pandemic, which causes inflammation and severe disease to lower the immune system response without suppressing it, thereby providing better corresponding treatment to the steroids, which completely suppress the immune system.

The second study is looking at the ACE2 receptor, which allows the virus to inject its genetic expression into human cells and proliferate. Moreover, as per Eybna’s CEO, Nadav Eyal, “This type of delivery method is a game-changer, empowering us to achieve therapeutic qualities from these unique phytochemicals like never before.”

We have observed the massive impact of novel coronavirus on people’s lives over the last five months. It has also impacted various industries across the globe, eventually affecting the global economy. Some industries have experienced negative growth, whereas some industries have experienced tremendous demand and have generated massive revenues in this period. Covid 19 Impact on CBD market is the one of the positive impact sector on global industry

CBD Market Dynamics

Growing research and development activities and financial support by various private and government organizations for cannabinoid research- There are many private and government organizations supporting the research and development for cannabinoids for medical purposes. Cannabis has numerous medicinal properties by which it can cure various diseases. According to the National Institute of Drug Abuse, May 2018 publication, in 2017, the National Institute of Health (NIH) supported 330 projects and spent USD 140 million on cannabinoid research and development. During this investment, USD 36 million was spent on 70 projects to examine the therapeutic properties of cannabis, and USD 15 million was spent on 26 projects centered on cannabinoid (CBD). Even in 2016, NIH spent USD 21 million studying the therapeutic properties of cannabinoids. Singapore, known for the world's most stringent drug laws, is also funding research projects on medical treatments containing synthetically derived compounds of the cannabis plant. In 2017, the government-run National Research Foundation launched a program to research the therapeutic potential of cannabinoids.

Segmentation

On the basis of form, the global cannabidiol market is segmented into solid and liquid.

In the solid form of CBD, the report covers CBD crystals, CBD wax, capsule/softgel, hash, and others. The liquid form of CBD includes CBD oil, tincture, cream, e-liquid, and others.

CBD crystals are a pure form of CBD isolates. CBD crystals are produced by heating CBD rich extract and then continuous cooling and separating it. CBD crystals are generally used to manufacture CBD infused edibles and creams. CBD wax is solidified or crystalized full spectrum form of CBD. CBD wax is a highly concentrated form of CBD and especially used for pain relief. CBD capsules are similar in comparison to capsules as they are surrounded by an outer shell, usually gelatin. CBD soft gelatin capsule is a translucent golden shade standard capsule that is filled with hemp oil and sometimes olive oil as filler.

CBD oil is one of the most popular and widely available forms of CBD. It is specifically used for medical purposes as it provides fast and effective results. There are a wide variety of flavors of full spectrum CBD oils available in the market. CBD tinctures are made from high strains of hemp, with 60-70% of alcohol. CBD tinctures are primarily used to relieve anxiety and ease the pain. CBD infused e-liquid are used as a fluid in electronic cigarettes and vaporizers.

CBD Market Key Players

The prominent players in the global CBD market are Aphria Inc., Folium Biosciences, Freedom Leaf, Inc, Green Roads of Florida, LLC, CBD Health Solutions, LLC, ENDOCA, Isodiol International Inc, CV Sciences, Inc, Medical Marijuana, Inc., Canopy Growth Corporation, Elixinol Global Limited.

The players operating in the global CBD market are focusing on product launches, along with expanding their global footprints by entering untapped markets.

CBD Market Regional Analysis

The Americas dominate the global CBD market, owing to the increasing consumption of cannabis-based products. According to the World Health Organization (WHO), the consumption of marijuana has an annual prevalence rate of nearly 2.5% of the global population, i.e., approximately 147 million individuals. It is also reported that approximately 22.2 million Americans of 12 years of age and older use cannabis and related products for various reasons.

Europe holds the second largest market share due to the rising awareness about clinical applications of cannabis. CBD is legal and can be openly marketed in certain European countries, for instance, the Ministry of Agriculture, Food and Forestry, and the Bulgarian Food Safety Agency issued the ‘free certificate of sale’ for the CBD products. Thus, such approvals and consideration by the regulatory agencies in Europe are driving the CBD market growth in the region. In spite of the approvals and considerations, there are positive restrictions associated with the use of the products. For instance, in 2013, medical cannabis was legalized in the Czech Republic, but it was limited to 180 grams of dry matter per month. In Europe, marijuana and cannabis laws differ from country to country. Previously, Germany was importing medical cannabis from other countries, but in 2017, Germany passed a law to expand access to medical cannabis and to allow domestic production. Increasing participation of various companies such as Medical Marijuana Inc., as a scope of development, announced the formation of Canipa Holdings in Romania, European Union. The effect of such initiatives by the companies is facilitating the growth of the CBD market in the European region.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/report/covid-19-impact-cbd-market

The Asia-Pacific region is classified into China, India, Japan, and Rest of Asia-Pacific. It holds the third largest position in the CBD market. Recently, China has legalized the cultivation of CBD (Hemp) and extraction for the derived product. The products are exported and not sold in China. Yunnan provincial government and Public Security Bureau approved the first industrial hemp plant extraction factory in China. It is the largest country in terms of area, population, businesses, and others. The entry of Chinese companies in the CBD market has created a great potential for expansion and growth. In Asia-Pacific, cannabis-based products are completely unacceptable. But due to the increasing cases of epilepsy, cannabis-based products are prescribed by some physicians. For instance, a recent Australian nationwide survey of 976 people with epilepsy indicated that 13% of the parents were using illicit cannabis extracts to manage their child’s seizures. Australia mainly focuses on the medical use of cannabis products. Australian regulatory agencies are operating on providing a guideline for the use of the CBD products. This is expected to help in the growth of the CBD market in Australia.

The Middle East and Africa is expected to witness a restricted growth due to stringent government policies, adverse effects associated with cannabis, and the illegal use of marijuana. In the Middle East, few of the Arab countries are imposing trick laws over the use and handling of cannabis-related products. Thus, the CBD market in these regions has limited scope for growth during the forecast period.

COVID-19 Impact on Coronary Stents Market In-Depth Analysis With Current Trends And Future Estimations

Market Research Future (MRFR) collected data on several factors including implications of covid-19 impact on microbiome sequencing services market and demographic challenges, showed how it could move forward in the coming years.

Coronary Stents Market Overview

Global Coronary Stents Market is expected to grow significantly over the forecast period. The market held a market value of USD 9,382.63 Million in 2017 and is projected to grow at a CAGR of 7.81% over the forecast period.

Coronary stents are used in the process of angioplasty to make the cross-section of the blood vessel wider. Stents hold the walls of the vessel and thus do not let it sag or shrink, thereby curing the blockages in the vessel. Coronary stents have substantially changed the practice of interventional cardiology by reducing early complications such as abrupt vessel closure and improving late clinical outcome (restenosis). This results in patient and physician satisfaction. Thus, this factor contributes heavily to the growth of this market.

Moreover, the wide acceptance of prosthesis in coronary artery treatment procedures also fuels the market growth. Key companies are also engaged in new product launches related to coronary stents owing to the wide acceptance of the product. For instance, in May 2018, Terumo Europe NV announced the launch of Ultimaster Tansei drug eluting stent in Europe.

The market, by coronary stents, is further segmented into drug eluting stents, bare metal stents, and bioresorbable vascular scaffolds. Drug-eluting stents are metal stents that have been coated with a pharmacologic drug known to suppress restenosis, whereas bare metal stents are stents without a covering or a coating. Bioresorbable vascular scaffolds are intended to provide mechanical support and drug delivery similar to drug eluting stents, followed by complete resorption in some years.

Impact of COVID – 19 on Coronary Stents Market:

An estimated two million people get coronary artery stents every year, according to the Harvard Health School. The current outbreak of COVID - 19 has affected the coronary stents market in several ways. The business complexities arising from the current pandemic has created confusion with respect to the production of medical devices. The solution to various multifaceted uncertainties experienced by coronary stent manufacturers, hospitals, surgical centers, and organizations working in the supply chain of these medical devices are covered in the restructured research report.

Based on a longtime voluntary registry, founded by the German Society for Thoracic and Cardiovascular Surgery (GSTCVS), well-defined data of all cardiac, thoracic, and vascular surgery procedures performed in 78 German heart surgery departments during the year 2018 were analyzed. For this period, a total of 174,902 procedures were submitted to the registry, 98,707 summarized as heart surgery procedures and 942 assist device implantations were registered. The growth in the cardiac surgeries can be explained with the help of infographic below.

We have observed the massive impact of novel coronavirus on people’s lives over the last five months. It has also impacted various industries across the globe, eventually affecting the global economy. Some industries have experienced negative growth, whereas some industries have experienced tremendous demand and have generated massive revenues in this period. Covid 19 Impact on Coronary Stents market is the one of the positive impact sector on global industry

Coronary Stents Market Competitive Analysis:

Abbott, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cook Medical, Elixir Medical Corporation, Medtronic plc, Meril Life Sciences,      MicroPort Scientific Corporation, Stentys SA, and Terumo Corporation are some of the key players in the global coronary stents market.

Coronary Stents Market Segmentation:

Global Coronary Stents Market has been segmented into products, and end user.Based on products, the market has been segmented into, Drug Eluting Stents, Bare Metal Stents, and Bioresorbable Vascular Scaffolds. The drug eluting stent segment is expected to account for the largest share in the global coronary stents market in 2017. This large share is majorly attributed to the wider acceptance of the drug eluting stents in the angioplasty procedures, better patient compliance as compared to the bare metal stents. On the other hand, bioresorbable stents are projected to grow at the fastest rate during the forecast period.

On the basis of end users, the market has been segmented into hospitals & clinics, ambulatory surgical centres, specialty centres, and others. The hospitals & clinics segment is expected to account for the largest share in the global coronary stents market in 2017. At the same time, the increasing establishments of the ambulatory surgical centres in the developed and developing countries has led this segment to grow at the fastest rate during the forecast period.Based on the regions, the market for coronary stents is segmented in to, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The coronary stents market in the Americas region has further been segmented into North America and South America, where-in the North American market is further divided into the US and Canada.

European Coronary Stents Market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The Coronary Stents Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The coronary stents market in the Middle East & Africa has been segmented into the Middle East and Africa.

Coronary Stents Market Regional Analysis:

Geographically, the Americas is anticipated to dominate the global coronary stents market owing to the rising prevalence of the cardiovascular diseases such as cardiac arrhythmia, arterial blockage, and coronary artery disease among others. The development of the better therapeutic approaches and advanced treatment procedures have affected the growth of the American market in a positive way. According to the data published by the Department of Health, New York in May 2018, percutaneous coronary intervention is one of the two most common procedures performed on patients with coronary artery disease. Besides this, the high medical awareness among American population, high disposable income, presence of the top medical device manufacturers in the region are some of the many factors that drive the growth of the coronary stents market in this region.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/report/covid-19-impact-coronary-stents-market  

Europe is expected to hold the second largest market share in the global coronary stents market. The market growth in this region is majorly attributed to the increasing government support for the device manufacturers. Geographical expansion of companies has led to the wider reach of the medical products and services which has brought a huge change in terms of the acceptance and implementation of the new products as well as procedures. Similarly, Asia-Pacific region has observed a rapid growth in the coronary stents market owing to the development in the medical sector in developing countries like India and China. Moreover, increase in government funding for healthcare, rising R&D expenditure, and growing number of medical device companies in the region has led to its fastest growth during the forecast period. The Middle East and Africa region is anticipated to show minor growth opportunities in the coronary stents market during the forecast period.